Investigational Study DrugsA Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Sponsor:

Washington University School of Medicine

Code:

NCT05552157

Conditions

Alzheimers Disease

Dementia

Alzheimers Disease, Familial

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Remternetug (SC)

Matching Placebo (Remternetug)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-20. This information was provided to ClinicalTrials.gov by Washington University School of Medicine on 2026-07-27.